만성 콩팥병 환자의 혈관 석회화

키워드

참고문헌 (96)

1. Goodman WG, "Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis", N Engl J Med, 342, pp.1478~1483 (2000)
2. Fang Y, "Early chronic kidney disease-mineral bone disorder stimulates vascular calcification", Kidney Int, 85, pp.142~150 (2014)
3. Mizobuchi M, "Vascular calcification : the killer of patients with chronic kidney disease", J Am Soc Nephrol, 20, pp.1453~1464 (2009)
4. Paloian NJ, "A current understanding of vascular calcification in CKD", Am J Physiol Renal Physiol, 307, pp.F891~F900 (2014)
5. Schlieper G, "Vascular calcification in chronic kidney disease : an update", Nephrol Dial Transplant, 31, pp.31~39 (2016)
6. Giachelli CM, "Vascular calcification mechanisms", J Am Soc Nephrol, 15, pp.2959~2964 (2004)
7. Wu M, "Vascular calcification : an update on mechanisms and challenges in treatment", Calcif Tissue Int, 93, pp.365~373 (2013)
8. Wyatt CM, "Vascular calcification in chronic kidney disease : here to stay", Kidney Int, 92, pp.276~278 (2017)
9. Palit S, "Vascular calcification in chronic kidney disease : role of disordered mineral metabolism", Curr Pharm Des, 20, pp.5829~5833 (2014)
10. Persy V, "Vascular calcification and bone disease : the calcification paradox", Trends Mol Med, 15, pp.405~416 (2009)
11. Bucay N, "Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification", Genes Dev, 12, pp.1260~1268 (1998)
12. Panizo S, "RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway", Circ Res, 104, pp.1041~1048 (2009)
13. Mesquita M, "Plasma osteoprotegerin is an independent risk factor for mortality and an early biomarker of coronary vascular calcification in chronic kidney disease", Clin Chem Lab Med, 47, pp.339~346 (2009)
14. Shao JS, "Msx2 promotes cardiovascular calcification by activating paracrine wnt signals", J Clin Invest, 115, pp.1210~1220 (2005)
15. Albanese I, "Atherosclerotic calcification : wnt is the hint", J Am Heart Assoc, 7, pp.e007356~ (2018)
16. Semenov MV, "Snapshot : noncanonical wnt signaling pathways", Cell, 131, pp.1378~ (2007)
17. Baron R, "Targeting wnt signaling in the treatment of osteoporosis", Curr Opin Pharmacol, 40, pp.134~141 (2018)
18. Khosla S, "Osteoporosis treatment : recent developments and ongoing challenges", Lancet Diabetes Endocrinol, 5, pp.898~907 (2017)
19. Pai A, "Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease", Am J Pathol, 178, pp.764~773 (2011)
20. Pai AS, "Matrix remodeling in vascular calcification associated with chronic kidney disease", J Am Soc Nephrol, 21, pp.1637~1640 (2010)
21. Aikawa E, "Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease", Circulation, 119, pp.1785~1794 (2009)
22. Moe SM, "Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease(CKD)", Kidney Int, 67, pp.2295~2304 (2005)
23. Price PA, "Matrix gla protein, a new gamma-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone", Biochem Biophys Res Commun, 117, pp.765~771 (1983)
24. Proudfoot D, "role of matrix gla protein", Nephrology(Carlton), 11, pp.455~461 (2006)
25. Roy ME, "Matrix gla protein binding to hydroxyapatite is dependent on the ionic environment : calcium enhances binding affinity but phosphate and magnesium decrease affinity", Bone, 31, pp.296~302 (2002)
26. Nigwekar SU, "Vitamin K-dependent carboxylation of matrix gla protein influences the risk of calciphylaxis", J Am Soc Nephrol, 28, pp.1717~1722 (2017)
27. Fusaro M, "Prevalence of vertebral fractures, vascular calcifications, and mortality in warfarin treated hemodialysis patients", Curr Vasc Pharmacol, 13, pp.248~258 (2015)
28. Rennenberg RJ, "Chronic coumarin treatment is associated with increased extracoronary arterial calcification in humans", Blood, 115, pp.5121~5123 (2010)
29. Tantisattamo E, "Increased vascular calcification in patients receiving warfarin", Arterioscler Thromb Vasc Biol, 35, pp.237~242 (2015)
30. Delanaye P, "Dephosphorylated-uncarboxylated matrix gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients", BMC Nephrol, 15, pp.145~ (2014)
31. Mayer O Jr, "Desphospho-uncarboxylated matrix gla-protein is associated with mortality risk in patients with chronic stable vascular disease", Atherosclerosis, 235, pp.162~168 (2014)
32. Schurgers LJ, "The circulating inactive form of matrix gla protein is a surrogate marker for vascular calcification in chronic kidney disease : a preliminary report", Clin J Am Soc Nephrol, 5, pp.568~575 (2010)
33. Reynolds JL, "Multifunctional roles for serum protein fetuin-a in inhibition of human vascular smooth muscle cell calcification", J Am Soc Nephrol, 16, pp.2920~2930 (2005)
34. Schafer C, "The serum protein alpha 2-Heremans-Schmid glycoprotein", fetuin-A is a systemically acting inhibitor of ectopic calcification, 2003, pp.112, 357~366
35. Ketteler M, "Association of low fetuin-A(AHSG)concentrations in serum with cardiovascular mortality in patients on dialysis : a cross-sectional study", Lancet, 361, pp.827~833 (2003)
36. Stenvinkel P, "Low fetuin-A levels are associated with cardiovascular death : impact of variations in the gene encoding fetuin", Kidney Int, 67, pp.2383~2392 (2005)
37. Coen G, "Cardiac calcifications : fetuin-A and other risk factors in hemodialysis patients", Asaio J, 52, pp.150~156 (2006)
38. Jung JY, "Association of AHSG gene polymorphisms and aortic stiffness in peritoneal dialysis patients", Am J Nephrol, 31, pp.510~517 (2010)
39. Mehrotra R, "Serum fetuin-A in nondialyzed patients with diabetic nephropathy : relationship with coronary artery calcification", Kidney Int, 67, pp.1070~1077 (2005)
40. Jung HH, "Inflammation, mineral metabolism and progressive coronary artery calcification in patients on haemodialysis", Nephrol Dial Transplant, 21, pp.1915~1920 (2006)
41. Jung JY, "Factors associated with aortic stiffness and its change over time in peritoneal dialysis patients", Nephrol Dial Transplant, 25, pp.4041~4048 (2010)
42. Scatena M, "Osteopontin : a multifunctional molecule regulating chronic inflammation and vascular disease", Arterioscler Thromb Vasc Biol, 27, pp.2302~2309 (2007)
43. Wolak T, "Osteopontin-a multi-modal marker and mediator in atherosclerotic vascular disease", Atherosclerosis, 236, pp.327~337 (2014)
44. Kaartinen MT, "Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of matrix gla protein-deficient mice", J Histochem Cytochem, 55, pp.375~386 (2007)
45. Rutsch F, "Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification", Nat Genet, 34, pp.379~381 (2003)
46. Lomashvili KA, "Vascular calcification is dependent on plasma levels of pyrophosphate", Kidney Int, 85, pp.1351~1356 (2014)
47. Lomashvili KA, "Reduced plasma pyrophosphate levels in hemodialysis patients", J Am Soc Nephrol, 16, pp.2495~2500 (2005)
48. Azpiazu D, "Role of pyrophosphate in vascular calcification in chronic kidney disease", Nefrologia, 38, pp.250~257 (2018)
49. Yang H, "Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro", Kidney Int, 66, pp.2293~2299 (2004)
50. Chen NX, "Verapamil inhibits calcification and matrix vesicle activity of bovine vascular smooth muscle cells", Kidney Int, 77, pp.436~442 (2010)
51. Giachelli CM, "The emerging role of phosphate in vascular calcification", Kidney Int, 75, pp.890~897 (2009)
52. Crouthamel MH, "Sodium-dependent phosphate cotransporters and phosphate-induced calcification of vascular smooth muscle cells : redundant roles for PiT-1 and PiT-2", Arterioscler Thromb Vasc Biol, 33, pp.2625~2632 (2013)
53. Li X, "Sodium-dependent phosphate cotransporters and vascular calcification", Curr Opin Nephrol Hypertens, 16, pp.325~328 (2007)
54. Nasrallah MM, "Fibroblast growth factor-23(FGF-23)is independently correlated to aortic calcification in haemodialysis patients", Nephrol Dial Transplant, 25, pp.2679~2685 (2010)
55. Scialla JJ, "Fibroblast growth factor 23 is not associated with and does not induce arterial calcification", Kidney Int, 83, pp.1159~1168 (2013)
56. Lee MJ, "Normal body mass index with central obesity has increased risk of coronary artery calcification in Korean patients with chronic kidney disease", Kidney Int, 90, pp.1368~1376 (2016)
57. Raggi P, "The advance study : a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis", Nephrol Dial Transplant, 26, pp.1327~1339 (2011)
58. Kuro-o M, "Calciprotein particle(CPP) : a true culprit of phosphorus woes", Nefrologia, 34, pp.1~4 (2014)
59. Miura Y, "Identification and quantification of plasma calciprotein particles with distinct physical properties in patients with chronic kidney disease", Sci Rep, 8, pp.1256~ (2018)
60. Pasch A, "Novel assessments of systemic calcification propensity", Curr Opin Nephrol Hypertens, 25, pp.278~284 (2016)
61. Pasch A, "Nanoparticle-based test measures overall propensity for calcification in serum", J Am Soc Nephrol, 23, pp.1744~1752 (2012)
62. Pasch A, "Blood calcification propensity, cardiovascular events, and survival in patients receiving hemodialysis in the evolve trial", Clin J Am Soc Nephrol, 12, pp.315~322 (2017)
63. Smith ER, "Serum calcification propensity predicts all-cause mortality in predialysis CKD", J Am Soc Nephrol, 25, pp.339~348 (2014)
64. Agatston AS, "Quantification of coronary artery calcium using ultrafast computed tomography", J Am Coll Cardiol, 15, pp.827~832 (1990)
65. Hokanson JE, "Evaluating changes in coronary artery calcium : an analytic method that accounts for interscan variability", AJR Am J Roentgenol, 182, pp.1327~1332 (2004)
66. Bellasi A, "Techniques and technologies to assess vascular calcification", Semin Dial, 20, pp.129~133 (2007)
67. Ogawa T, "Simple evaluation of aortic arch calcification by chest radiography in hemodialysis patients", Hemodial Int, 13, pp.301~306 (2009)
68. Inoue T, "Aortic arch calcification evaluated on chest X-ray is a strong independent predictor of cardiovascular events in chronic hemodialysis patients", Heart Vessels, 27, pp.135~142 (2012)
69. Kauppila LI, "New indices to classify location, severity and progression of calcific lesions in the abdominal aorta : a 25-year follow-up study", Atherosclerosis, 132, pp.245~250 (1997)
70. Bellasi A, "Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients", Kidney Int, 70, pp.1623~1628 (2006)
71. Adragao T, "A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients", Nephrol Dial Transplant, 19, pp.1480~1488 (2004)
72. Kidney Disease: Improving Global Outcomes (KDIGO)CKD-MBD Update Work Group, "KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)", Kidney Int Suppl, 7, pp.1~59 (2017)
73. Drüeke TB, "Calcium balance in haemodialysis--do not lower the dialysate calcium concentration too much(con part)", Nephrol Dial Transplant, 24, pp.2990~2993 (2009)
74. Gotch FA, "Pro", Con debate : the calculation on calcium balance in dialysis lowers the dialysate calcium concentrations(pro part), 2009, pp.24, 2994~2996
75. Miyagawa A, "The sodium phosphate cotransporter family and nicotinamide phosphoribosyltransferase contribute to the daily oscillation of plasma inorganic phosphate concentration", Kidney Int, 93, pp.1073~1085 (2018)
76. Block GA, "Effects of phosphate binders in moderate CKD", J Am Soc Nephrol, 23, pp.1407~1415 (2012)
77. Jamal SA, "Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease : an updated systematic review and meta-analysis", Lancet, 382, pp.1268~1277 (2013)
78. Teng M, "Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy", N Engl J Med, 349, pp.446~456 (2003)
79. Teng M, "Activated injectable vitamin D and hemodialysis survival : a historical cohort study", J Am Soc Nephrol, 16, pp.1115~1125 (2005)
80. Mizobuchi M, "Differential effects of vitamin D receptor activators on vascular calcification in uremic rats", Kidney Int, 72, pp.709~715 (2007)
81. Becker LE, "Effect of paricalcitol and calcitriol on aortic wall remodeling in uninephrectomized ApoE knockout mice", Am J Physiol Renal Physiol, 300, pp.F772~F782 (2011)
82. Mathew S, "Vitamin D receptor activators can protect against vascular calcification", J Am Soc Nephrol, 19, pp.1509~1519 (2008)
83. Ogawa T, "Relation of oral 1alpha-hydroxy vitamin D3 to the progression of aortic arch calcification in hemodialysis patients", Heart Vessels, 25, pp.1~6 (2010)
84. Petchey WG, "Multimodality vascular imaging in CKD : divergence of risk between measured parameters", Nephrol Dial Transplant, 27, pp.1004~1012 (2012)
85. Thadhani R, "Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease : the PRIMO randomized controlled trial", JAMA, 307, pp.674~684 (2012)
86. EVOLVE Trial Investigators, "Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis", N Engl J Med, 367, pp.2482~2494 (2012)
87. Hashiba H, "Inhibition of the progression of aortic calcification by etidronate treatment in hemodialysis patients : long-term effects", Ther Apher Dial, 10, pp.59~64 (2006)
88. Hashiba H, "Inhibitory effects of etidronate on the progression of vascular calcification in hemodialysis patients", Ther Apher Dial, 8, pp.241~247 (2004)
89. Toussaint ND, "Effect of alendronate on vascular calcification in CKD stages 3 and 4 : a pilot randomized controlled trial", Am J Kidney Dis, 56, pp.57~68 (2010)
90. Elmariah S, "Bisphosphonate use and prevalence of valvular and vascular calcification in women MESA(the multi-rthnic study of atherosclerosis)", J Am Coll Cardiol, 56, pp.1752~1759 (2010)
91. Helas S, "Inhibition of receptor activator of NF-kappaB ligand by denosumab attenuates vascular calcium deposition in mice", Am J Pathol, 175, pp.473~478 (2009)
92. Samelson EJ, "RANKL inhibition with denosumab does not influence 3-year progression of aortic calcification or incidence of adverse cardiovascular events in postmenopausal women with osteoporosis and high cardiovascular risk", J Bone Miner Res, 29, pp.450~457 (2014)
93. Mathews SJ, "Effects of sodium thiosulfate on vascular calcification in end-stage renal disease : a pilot study of feasibility, safety and efficacy", Am J Nephrol, 33, pp.131~138 (2011)
94. Saengpanit D, "Effect of sodium thiosulfate on arterial stiffness in end-stage renal disease patients undergoing chronic hemodialysis(sodium thiosulfate-hemodialysis study) : a randomized controlled trial", Nephron, 139, pp.219~227 (2018)
95. Weijs B, "Patients using vitamin K antagonists show increased levels of coronary calcification : an observational study in low-risk atrial fibrillation patients", Eur Heart J, 32, pp.2555~2562 (2011)
96. Westenfeld R, "Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients : a randomized trial", Am J Kidney Dis, 59, pp.186~195 (2012)

관련 논문AI추천